140
Can deviation from NICE guideline TA314 ever be justified?

EP Europace Journal

10 October 2018

Organised by:

Read full article

Contributors

P Brady

P Brady

Author

B Chandrasekaran

B Chandrasekaran

Author

P Foley

P Foley

Author

You may be interested in

Congress Presentation

Natriuretic peptide referral thresholds and heart failure diagnosis: population-based cohort study

27 August 2021

Congress Presentation

Cost-effectiveness of statin therapy in categories of patients in the UK

27 August 2022

Congress Presentation

Guideline adherence to echocardiographic monitoring of aortic stenosis

12 December 2024

Congress Session

What counts as convincing? Revisiting levels of evidence for ESC Guidelines

30 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources